Related Experiment Video
Updated: Aug 17, 2026

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
Published on: July 25, 2013
Novel selective inhibitors for human topoisomerase I, BM2419-1 and -2 derived from saintopin
D Ishiyama1, K Futamata, M Futamata
1Drug Discovery Research Laboratories, Kaken Pharmaceutical CO., LTD., Shizuoka, Japan.
Abstract:
Compounds BM2419-1 and -2 were isolated from a culture broth of a fungus Paecilomyces sp. BM2419. It was shown that these novel compounds were artifacts derived from saintopin, a dual inhibitor of topoisomerase I and II by independent processes. In the human topoisomerase I inhibition assay using the recombinant Saccharomyces cerevisiae, BM2419-1 and -2 inhibited selectively the yeast growth dependent on human topoisomerase I induction with IC50 values of 0.3 ng/ml and 6.0 ng/ml, respectively.
Related Concept Videos
DNA Topoisomerases
Types and Mechanism of action
Topoisomerases are divided into two main types. Type I...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Inhibitors of Bacterial DNA Synthesis
Inhibitors of Viral Protein Synthesis
Antiviral Nucleoside Inhibitors
Antifungal Agents

